Table 2.
Microorganism strains | MSI-1 (µg/ml) | Melittin (µg/ml) | ||||
---|---|---|---|---|---|---|
MIC | MBC | MIC | MBC | |||
G- | ||||||
E. coli a | 4 | 16 | 4 | 8 | ||
P. aeruginosa a | 8 | 32 | 4 | 8 | ||
Helicobacterpylori SS1 | 32 | 64 | 8 | 16 | ||
E. coli BL21(DE3)-NDM-1b | 8 | 8 | 4 | 8 | ||
K. pneumonia a | 16 | 32 | 8 | 16 | ||
G+ | S. aureus c | 8 | 16 | 8 | 32 | |
S. epidermidis c | 8 | 16 | 4 | 16 | ||
S. pneumoniae c | 8 | 32 | 8 | 16 | ||
S. pyogenes d | 16 | 32 | 8 | 16 | ||
MRSA e | 8 | 16 | 4 | 8 | ||
a Penicillin-, Imipenem- and Ceftazidime- resistant clinical isolates.
b ndm-1-carrying recombinant E. coli 33
c Amoxicillin-, Cephalexin- and Levofloxacin- resistant clinical isolates.
d Penicillin-, Erythromycin- and Levofloxacin- resistant clinical isolates.
e Methicillin-resistant clinical isolates.